Search research articles
Contact Us
Filters
Showing results (461-470 of 538) with videos related to
Page
of 54
Sort By:
Circulation. Cardiovascular Quality and Outcomes
|
June 14, 2013
End of study transition from study drug to open-label vitamin K antagonist therapy: the ROCKET AF experience
Kenneth W Mahaffey, Anne S Hellkamp, Manesh R Patel, et al.
European Heart Journal. Quality of Care & Clinical Outcomes
|
April 23, 2021
GARFIELD-AF risk score for mortality, stroke, and bleeding within 2 years in patients with atrial fibrillation
Keith A A Fox, Saverio Virdone, Karen S Pieper, et al.
European Heart Journal
|
September 12, 2014
Higher risk of death and stroke in patients with persistent vs. paroxysmal atrial fibrillation: results from the ROCKET-AF Trial
Benjamin A Steinberg, Anne S Hellkamp, Yuliya Lokhnygina, et al.
Heart Rhythm
|
August 14, 2018
Updated performance of the Micra transcatheter pacemaker in the real-world setting: A comparison to the investigational study and a transvenous historical control
Mikhael F El-Chami, Faisal Al-Samadi, Nicolas Clementy, et al.
American Heart Journal
|
December 21, 2021
Achievement and quality measure attainment in patients hospitalized with atrial fibrillation: Results from The Get With The Guidelines - Atrial Fibrillation (GWTG-AFIB) registry
Aditya J Ullal, DaJuanicia N Holmes, Barbara L Lytle, et al.
Heart Rhythm O2
|
March 4, 2022
Dose-limiting, adverse event-associated bradycardia with β-blocker treatment of atrial fibrillation in the GENETIC-AF trial
William T Abraham, Jonathan P Piccini, Christopher Dufton, et al.
Circulation. Arrhythmia and Electrophysiology
|
November 11, 2023
Multicenter, Phase 2, Randomized Controlled Study of the Efficacy and Safety of Etripamil Nasal Spray for the Acute Reduction of Rapid Ventricular Rate in Patients With Symptomatic Atrial Fibrillation (ReVeRA-201)
A John Camm, Jonathan P Piccini, Marco Alings, et al.
The American Journal of Cardiology
|
August 23, 2020
Effect of Temporary Interruption of Warfarin Due to an Intervention on Downstream Time in Therapeutic Range in Patients With Atrial Fibrillation (from ORBIT AF)
Malini Madhavan, DaJuanicia N Holmes, Jonathan P Piccini, et al.
Lancet (London, England)
|
June 18, 2023
Self-administered intranasal etripamil using a symptom-prompted, repeat-dose regimen for atrioventricular-nodal-dependent supraventricular tachycardia (RAPID): a multicentre, randomised trial
Bruce S Stambler, A John Camm, Marco Alings, et al.
Circulation
|
February 9, 2022
MRI-Detected Brain Lesions and Cognitive Function in Patients With Atrial Fibrillation Undergoing Left Atrial Catheter Ablation in the Randomized AXAFA-AFNET 5 Trial
Karl Georg Haeusler, Felizitas A Eichner, Peter U Heuschmann, et al.
Page
of 54
Search research articles
Search
Showing results (461-470 of 538) with videos related to
Sort By:
Page
of 54
Circulation. Cardiovascular Quality and Outcomes
|
June 14, 2013
End of study transition from study drug to open-label vitamin K antagonist therapy: the ROCKET AF experience
Kenneth W Mahaffey, Anne S Hellkamp, Manesh R Patel, et al.
European Heart Journal. Quality of Care & Clinical Outcomes
|
April 23, 2021
GARFIELD-AF risk score for mortality, stroke, and bleeding within 2 years in patients with atrial fibrillation
Keith A A Fox, Saverio Virdone, Karen S Pieper, et al.
European Heart Journal
|
September 12, 2014
Higher risk of death and stroke in patients with persistent vs. paroxysmal atrial fibrillation: results from the ROCKET-AF Trial
Benjamin A Steinberg, Anne S Hellkamp, Yuliya Lokhnygina, et al.
Heart Rhythm
|
August 14, 2018
Updated performance of the Micra transcatheter pacemaker in the real-world setting: A comparison to the investigational study and a transvenous historical control
Mikhael F El-Chami, Faisal Al-Samadi, Nicolas Clementy, et al.
American Heart Journal
|
December 21, 2021
Achievement and quality measure attainment in patients hospitalized with atrial fibrillation: Results from The Get With The Guidelines - Atrial Fibrillation (GWTG-AFIB) registry
Aditya J Ullal, DaJuanicia N Holmes, Barbara L Lytle, et al.
Heart Rhythm O2
|
March 4, 2022
Dose-limiting, adverse event-associated bradycardia with β-blocker treatment of atrial fibrillation in the GENETIC-AF trial
William T Abraham, Jonathan P Piccini, Christopher Dufton, et al.
Circulation. Arrhythmia and Electrophysiology
|
November 11, 2023
Multicenter, Phase 2, Randomized Controlled Study of the Efficacy and Safety of Etripamil Nasal Spray for the Acute Reduction of Rapid Ventricular Rate in Patients With Symptomatic Atrial Fibrillation (ReVeRA-201)
A John Camm, Jonathan P Piccini, Marco Alings, et al.
The American Journal of Cardiology
|
August 23, 2020
Effect of Temporary Interruption of Warfarin Due to an Intervention on Downstream Time in Therapeutic Range in Patients With Atrial Fibrillation (from ORBIT AF)
Malini Madhavan, DaJuanicia N Holmes, Jonathan P Piccini, et al.
Lancet (London, England)
|
June 18, 2023
Self-administered intranasal etripamil using a symptom-prompted, repeat-dose regimen for atrioventricular-nodal-dependent supraventricular tachycardia (RAPID): a multicentre, randomised trial
Bruce S Stambler, A John Camm, Marco Alings, et al.
Circulation
|
February 9, 2022
MRI-Detected Brain Lesions and Cognitive Function in Patients With Atrial Fibrillation Undergoing Left Atrial Catheter Ablation in the Randomized AXAFA-AFNET 5 Trial
Karl Georg Haeusler, Felizitas A Eichner, Peter U Heuschmann, et al.
Page
of 54